Mission Wealth Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $241K | Sell |
1,915
-295
| -13% | -$37.1K | 0.01% | 590 |
|
|
2025
Q1 | $244K | Buy |
2,210
+400
| +22% | +$44.2K | 0.01% | 567 |
|
|
2024
Q4 | $247K | Buy |
+1,810
| New | +$247K | 0.01% | 554 |
|
|
2024
Q3 | – | Sell |
-1,725
| Closed | -$237K | – | 651 |
|
|
2024
Q2 | $237K | Hold |
1,725
| – | – | 0.01% | 549 |
|
|
2024
Q1 | $238K | Sell |
1,725
-75
| -4% | -$10.3K | 0.01% | 564 |
|
|
2023
Q4 | $237K | Sell |
1,800
-1,525
| -46% | -$201K | 0.01% | 501 |
|
|
2023
Q3 | $374K | Hold |
3,325
| – | – | 0.01% | 387 |
|
|
2023
Q2 | $314K | Hold |
3,325
| – | – | 0.01% | 430 |
|
|
2023
Q1 | $337K | Hold |
3,325
| – | – | 0.01% | 402 |
|
|
2022
Q4 | $397K | Buy |
3,325
+10
| +0.3% | +$1.19K | 0.02% | 355 |
|
|
2022
Q3 | $352K | Hold |
3,315
| – | – | 0.02% | 344 |
|
|
2022
Q2 | $323K | Hold |
3,315
| – | – | 0.02% | 369 |
|
|
2022
Q1 | $311K | Hold |
3,315
| – | – | 0.01% | 393 |
|
|
2021
Q4 | $282K | Hold |
3,315
| – | – | 0.01% | 427 |
|
|
2021
Q3 | $318K | Hold |
3,315
| – | – | 0.02% | 377 |
|
|
2021
Q2 | $323K | Hold |
3,315
| – | – | 0.02% | 370 |
|
|
2021
Q1 | $322K | Sell |
3,315
-1,204
| -27% | -$117K | 0.02% | 347 |
|
|
2020
Q4 | $433K | Hold |
4,519
| – | – | 0.03% | 267 |
|
|
2020
Q3 | $435K | Sell |
4,519
-1,205
| -21% | -$116K | 0.03% | 220 |
|
|
2020
Q2 | $698K | Buy |
5,724
+2,309
| +68% | +$282K | 0.06% | 151 |
|
|
2020
Q1 | $296K | Sell |
3,415
-12,045
| -78% | -$1.04M | 0.03% | 212 |
|
|
2019
Q4 | $1.66M | Buy |
15,460
+5,088
| +49% | +$547K | 0.16% | 83 |
|
|
2019
Q3 | $935K | Sell |
10,372
-2,500
| -19% | -$225K | 0.1% | 107 |
|
|
2019
Q2 | $1.09M | Sell |
12,872
-12,746
| -50% | -$1.08M | 0.12% | 91 |
|
|
2019
Q1 | $2.26M | Buy |
25,618
+12,784
| +100% | +$1.13M | 0.26% | 59 |
|
|
2018
Q4 | $916K | Buy |
+12,834
| New | +$916K | 0.12% | 95 |
|
|
2018
Q2 | – | Sell |
-2,625
| Closed | -$218K | – | 277 |
|
|
2018
Q1 | $218K | Hold |
2,625
| – | – | 0.04% | 209 |
|
|
2017
Q4 | $204K | Buy |
+2,625
| New | +$204K | 0.03% | 212 |
|